Nov. 4 (Bloomberg) — CVS Health Corp. beat analyst's third-quarter estimates as prescription drug sales made up for the loss the company suffered after it quit selling tobacco products at its retail pharmacies.

Profit excluding one-time items of $1.15 a share beat by 2 cents the average of analysts' estimates compiled by Bloomberg. Revenue at the front of the store, where CVS previously sold tobacco items, fell 4.5 percent, based on same-store sales.

CVS stopped selling tobacco products and changed its name to CVS Health in September to focus on the medical side of its operations at its 7,700 drugstores. None of its rivals have followed suit on cigarettes, a step the company has said will cost it about $2 billion a year in revenue.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.